Volume 24, Number 1—January 2018
Dispatch
High Seroprevalence of Jamestown Canyon Virus among Deer and Humans, Nova Scotia, Canada
Table 2
Characteristic | No. tested | No. (%) positive | Adjusted proportion (95% CI) | p value* |
---|---|---|---|---|
Sex | 0.013 |
|||
M | 151 | 51 (33.8) | 26.8 (19.9–35.0) | |
F |
150 |
30 (20.0) |
14.4 (9.3–21.5) |
|
Age group, y | 0.024 |
|||
10–19 | 43 | 6 (14.0) | 10.8 (4.0–25.8) | |
20–29 | 54 | 13 (24.1) | 20.4 (11.0–34.5) | |
30–39 | 52 | 12 (23.1) | 14.1 (6.9–26.7) | |
40–49 | 60 | 15 (25.0) | 20.4 (1.6–33.3) | |
50–59 | 61 | 21 (34.4) | 27.8 (17.1–41.7) | |
60–64 |
31 |
14 (45.2) |
33.0 (17.7–53.0) |
|
District Health Authority | 0.004 | |||
1 | 81 | 39 (48.2) | 48.2† (37.4–59.1) | |
2–8 | 115 | 26 (22.6) | 22.6† (15.8–31.4) | |
9 |
105 |
16 (15.2) |
15.2† (9.5–23.5) |
|
Total no. | 301 | 81 (26.9) | 20.6 (16.0–25.9) |
*Pearson χ2 for test by DHA; corrected Pearson χ2 for test by sex; logistic regression test for trend by age group.
†Adjustment was unnecessary for estimates made by the DHA because weighting was done by this authority.
Page created: December 19, 2017
Page updated: December 19, 2017
Page reviewed: December 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.